ZUH:CA:TSX-BMO Equal Weight US Health Care (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 69.93

Change

+0.64 (+0.92)%

Market Cap

CAD 0.23B

Volume

1.63K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-23 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.07 (+0.15%)

CAD 3.39B
ZWU:CA BMO Covered Call Utilities ETF

+0.01 (+0.09%)

CAD 1.82B
XIT:CA iShares S&P/TSX Capped Informa..

+0.18 (+0.25%)

CAD 0.78B
TXF:CA First Asset Tech Giants Covere..

+0.03 (+0.14%)

CAD 0.66B
HTA:CA Harvest Tech Achievers Growth ..

-0.01 (-0.05%)

CAD 0.65B
XHC:CA iShares Global Healthcare (CAD..

+0.69 (+1.03%)

CAD 0.54B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.17 (+0.79%)

CAD 0.51B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.28 (+1.01%)

CAD 0.40B
CWW:CA iShares Global Water Common Cl..

+0.07 (+0.12%)

CAD 0.30B
COW:CA iShares Global Agriculture Com..

+1.02 (+1.52%)

CAD 0.28B

ETFs Containing ZUH:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.42% 97% N/A 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.42% 97% N/A 86% B+
Trailing 12 Months  
Capital Gain 1.79% 29% F 24% F
Dividend Return 0.71% 28% F 8% B-
Total Return 2.50% 17% F 17% F
Trailing 5 Years  
Capital Gain 14.79% 37% F 50% F
Dividend Return 2.73% 21% F 5% F
Total Return 17.52% 23% F 36% F
Average Annual (5 Year Horizon)  
Capital Gain 3.59% 34% F 46% F
Dividend Return 4.00% 23% F 41% F
Total Return 0.41% 29% F 26% F
Risk Return Profile  
Volatility (Standard Deviation) 15.92% 63% D 53% F
Risk Adjusted Return 25.12% 17% F 39% F
Market Capitalization 0.23B 65% D 48% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.